var data={"title":"Herpetic gingivostomatitis in young children","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Herpetic gingivostomatitis in young children</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/contributors\" class=\"contributor contributor_credentials\">Martha Ann Keels, DDS, PhD</a></dd><dd><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/contributors\" class=\"contributor contributor_credentials\">Dennis A Clements, MD, PhD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/contributors\" class=\"contributor contributor_credentials\">Sheldon L Kaplan, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/contributors\" class=\"contributor contributor_credentials\">Ann Griffen, DDS, MS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/contributors\" class=\"contributor contributor_credentials\">Mary M Torchia, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 30, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gingivostomatitis is the most common manifestation of primary herpes simplex virus (HSV) infection during childhood [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1\" class=\"abstract_t\">1</a>]. Primary herpetic gingivostomatitis is characterized by ulcerative lesions of the gingiva and mucous membranes of the mouth (<a href=\"image.htm?imageKey=PEDS%2F58944\" class=\"graphic graphic_picture graphicRef58944 \">picture 1</a>), often with perioral vesicular lesions (<a href=\"image.htm?imageKey=PEDS%2F58542\" class=\"graphic graphic_picture graphicRef58542 \">picture 2</a>).</p><p>The clinical features, diagnosis, management, and prevention of herpetic gingivostomatitis will be discussed here. Neonatal herpes simplex virus infection is discussed separately. (See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical manifestations of mucocutaneous herpes simplex virus type 1 (HSV-1) disease are due to tissue destruction, a direct consequence of viral replication and cell lysis [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1\" class=\"abstract_t\">1</a>]. Inoculation of HSV-1 at mucosal surfaces or skin sites permits entry of the virus into sensory and autonomic nerve endings through which it is transported to the cell nuclei (eg, the trigeminal ganglion), where it remains latent. Reactivation results in recurrent herpes simplex virus disease (eg, herpes gingivostomatitis, herpes labialis). (See <a href=\"topic.htm?path=pathogenesis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">&quot;Pathogenesis of herpes simplex virus type 1 infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">VIROLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Herpetic gingivostomatitis is caused by herpes simplex virus type 1 [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Primary herpetic gingivostomatitis typically occurs in children between six months and five years of age, but it can occur in older children and adolescents [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;</a>.)</p><p>Herpetic gingivostomatitis occurs throughout the year, with no particular seasonal distribution [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/2\" class=\"abstract_t\">2</a>]. In a retrospective review at a single institution, herpes simplex virus (HSV) gingivostomatitis was diagnosed in 1.6 per 10,000 emergency department visits and 5.6 per 10,000 hospital admissions [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HSV type 1 (HSV-1) infections usually result from direct contact with infected oral secretions or lesions. HSV infections can be transmitted from symptomatic or asymptomatic individuals with primary or recurrent HSV infection [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4\" class=\"abstract_t\">4</a>].</p><p>Children with primary gingivostomatitis typically shed HSV for at least one week and occasionally for several weeks (median three weeks) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4,5\" class=\"abstract_t\">4,5</a>]. Intermittent asymptomatic reactivation and shedding occurs throughout life [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4-6\" class=\"abstract_t\">4-6</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Incubation period</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incubation period for HSV infection beyond the neonatal period ranges from two days to two weeks, with a mean of four days [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/2,5,7\" class=\"abstract_t\">2,5,7</a>]. (See <a href=\"topic.htm?path=epidemiology-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">&quot;Epidemiology of herpes simplex virus type 1 infection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gingivostomatitis is the most common manifestation of primary herpes simplex virus (HSV) infection [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1\" class=\"abstract_t\">1</a>]. It occurs in 13 to 30 percent of affected children [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/8-11\" class=\"abstract_t\">8-11</a>].</p><p>Primary herpetic gingivostomatitis is characterized by ulcerative lesions of the gingiva and mucous membranes of the mouth (<a href=\"image.htm?imageKey=PEDS%2F58944\" class=\"graphic graphic_picture graphicRef58944 \">picture 1</a>), often with perioral vesicular lesions (<a href=\"image.htm?imageKey=PEDS%2F58542\" class=\"graphic graphic_picture graphicRef58542 \">picture 2</a>). Herpetic gingivostomatitis occurs approximately one week after contact with an infected child or adult (the contact case often is asymptomatic). It generally begins with a prodrome that lasts approximately four days and may include fever (&gt;38&deg;C [100.4&deg;F]), anorexia, irritability, malaise, sleeplessness, and headache [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1,12,13\" class=\"abstract_t\">1,12,13</a>]. Parents may attribute these symptoms to teething in children whose primary teeth are erupting, but children who are teething do not have oropharyngeal lesions [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/14\" class=\"abstract_t\">14</a>].</p><p>The eruption on the oral mucosa begins with red, edematous marginal gingivae that bleed easily and clusters of small vesicles (<a href=\"image.htm?imageKey=PEDS%2F58944\" class=\"graphic graphic_picture graphicRef58944 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1,12,13\" class=\"abstract_t\">1,12,13</a>]. The vesicles become yellow after rupture and are surrounded by a red halo. They coalesce to form large, painful ulcers of the oral and perioral tissues (<a href=\"image.htm?imageKey=PEDS%2F58542\" class=\"graphic graphic_picture graphicRef58542 \">picture 2</a> and <a href=\"image.htm?imageKey=PEDS%2F73566\" class=\"graphic graphic_picture graphicRef73566 \">picture 3</a>). They bleed easily and may become covered with a black crust [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/15\" class=\"abstract_t\">15</a>]. The lesions involve the buccal mucosa, tongue, gingiva, hard palate, and pharynx; the lips and perioral skin are affected in approximately two-thirds of cases [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1,8\" class=\"abstract_t\">1,8</a>]. Mild lesions typically heal without scarring in approximately a week, but healing may require 14 to 21 days in severe cases [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1,12\" class=\"abstract_t\">1,12</a>]. (See <a href=\"#H12\" class=\"local\">'Natural history'</a> below.)</p><p>Associated symptoms and signs may include bad breath, refusal to drink, anorexia, fever, arthralgia, headache, and submandibular or cervical lymphadenitis [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1,8\" class=\"abstract_t\">1,8</a>]. Refusal to drink may result in dehydration, which is the most frequent complication. (See <a href=\"#H8\" class=\"local\">'Complications'</a> below.)</p><p>After the primary infection, HSV migrates to the trigeminal ganglion, where it remains in a latent state unless it is reactivated. Reactivation can be induced by exposure to sunlight, cold, trauma, stress, or immunosuppression and may occur in the oral cavity (recurrent stomatitis) or on the lips (herpes labialis) (<a href=\"image.htm?imageKey=PEDS%2F115299\" class=\"graphic graphic_picture graphicRef115299 \">picture 4</a>). Herpes labialis is discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;</a> and <a href=\"topic.htm?path=treatment-of-herpes-simplex-virus-type-1-infection-in-immunocompetent-patients#H10\" class=\"medical medical_review\">&quot;Treatment of herpes simplex virus type 1 infection in immunocompetent patients&quot;, section on 'Recurrent infections'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">COMPLICATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Complications of herpetic gingivostomatitis may include [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1,8,16\" class=\"abstract_t\">1,8,16</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dehydration (the most common complication), which may require hospitalization for parenteral fluid therapy (see <a href=\"topic.htm?path=clinical-assessment-and-diagnosis-of-hypovolemia-dehydration-in-children\" class=\"medical medical_review\">&quot;Clinical assessment and diagnosis of hypovolemia (dehydration) in children&quot;</a> and <a href=\"topic.htm?path=maintenance-fluid-therapy-in-children\" class=\"medical medical_review\">&quot;Maintenance fluid therapy in children&quot;</a> and <a href=\"topic.htm?path=treatment-of-hypovolemia-dehydration-in-children\" class=\"medical medical_review\">&quot;Treatment of hypovolemia (dehydration) in children&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpetic whitlow (<a href=\"image.htm?imageKey=DERM%2F75510%7EID%2F52029\" class=\"graphic graphic_picture graphicRef75510 graphicRef52029 \">picture 5A-B</a>) or herpetic keratitis (<a href=\"image.htm?imageKey=ID%2F69359\" class=\"graphic graphic_picture graphicRef69359 \">picture 6</a>) from autoinoculation (see <a href=\"topic.htm?path=paronychia\" class=\"medical medical_review\">&quot;Paronychia&quot;</a> and <a href=\"topic.htm?path=herpes-simplex-keratitis\" class=\"medical medical_review\">&quot;Herpes simplex keratitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Secondary bacteremia with upper respiratory bacteria (eg, <em>Streptococcus pyogenes</em>, <em>Kingella kingae</em>) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/16,17\" class=\"abstract_t\">16,17</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Esophagitis, epiglottitis, or pneumonitis (particularly in immunocompromised children) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/18\" class=\"abstract_t\">18</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpes simplex virus (HSV) encephalitis (see <a href=\"topic.htm?path=herpes-simplex-virus-type-1-encephalitis\" class=\"medical medical_review\">&quot;Herpes simplex virus type 1 encephalitis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eczema herpeticum in children with atopic dermatitis and other dermatitides (<a href=\"image.htm?imageKey=PC%2F74838\" class=\"graphic graphic_picture graphicRef74838 \">picture 7</a> and <a href=\"image.htm?imageKey=PC%2F64142\" class=\"graphic graphic_picture graphicRef64142 \">picture 8</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lip adhesions, which may be prevented through the application of lip barrier cream [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/19\" class=\"abstract_t\">19</a>]</p><p/><p>Complications in immunocompromised patients include severe local lesions, disseminated HSV infection with visceral involvement, HSV pneumonitis, and HSV encephalitis [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1,4\" class=\"abstract_t\">1,4</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of gingivostomatitis generally is made clinically, based upon the typical appearance and location of oral and extraoral lesions (<a href=\"image.htm?imageKey=PEDS%2F58944\" class=\"graphic graphic_picture graphicRef58944 \">picture 1</a> and <a href=\"image.htm?imageKey=PEDS%2F58542\" class=\"graphic graphic_picture graphicRef58542 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/8\" class=\"abstract_t\">8</a>].</p><p>In cases where it is necessary to confirm an etiologic diagnosis, herpes simplex virus type 1 (HSV-1) can be diagnosed with viral culture, serology, immunofluorescence, or polymerase chain reaction. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection#H25\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;, section on 'Diagnosis'</a>.)</p><p>The Tzanck smear, which demonstrates the cytopathic effect of herpes viruses, can be performed in patients with active lesions. However, it has limited utility because it is only helpful if it is positive and does not distinguish between HSV-1, HSV-2, and varicella zoster virus. (See <a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures#H12\" class=\"medical medical_review\">&quot;Office-based dermatologic diagnostic procedures&quot;, section on 'Tzanck smear'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Herpes simplex virus (HSV) gingivostomatitis must be differentiated from a number of other conditions with oral lesions because the treatment, clinical course, <span class=\"nowrap\">and/or</span> public health implications may differ (eg, herpangina; hand, foot, and mouth disease; oral candidiasis; aphthous ulcers; Stevens-Johnson syndrome; and Beh&ccedil;et syndrome) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/8\" class=\"abstract_t\">8</a>]. HSV gingivostomatitis can usually be differentiated from these conditions by the presence, appearance, and location of oral and extraoral lesions [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/12\" class=\"abstract_t\">12</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpangina &ndash; Herpangina, which is usually caused by group A coxsackieviruses, typically causes painful posterior pharyngeal lesions that do not bleed, has a more acute onset and shorter duration than HSV gingivostomatitis, and occurs primarily in the summer and early fall [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/15,20\" class=\"abstract_t\">15,20</a>]. (See <a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">&quot;Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hand, foot, and mouth disease &ndash; Hand, foot, and mouth disease (<a href=\"image.htm?imageKey=PEDS%2F52800%7EDERM%2F58566%7EDERM%2F53423%7EDERM%2F71314\" class=\"graphic graphic_picture graphicRef52800 graphicRef58566 graphicRef53423 graphicRef71314 \">picture 9A-D</a>) is caused by a number of coxsackie A and B viruses. It occurs in the spring and early summer. The extremity lesions usually are bilateral (in contrast to herpetic whitlow, which typically is unilateral) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/15\" class=\"abstract_t\">15</a>]. (See <a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Enterovirus and parechovirus infections: Epidemiology and pathogenesis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral candidiasis &ndash; Oral candidiasis is characterized by white plaques on the buccal mucosa, palate, tongue, or oropharynx (<a href=\"image.htm?imageKey=PEDS%2F69465\" class=\"graphic graphic_picture graphicRef69465 \">picture 10</a>). It occurs in infants after exposure to the microorganisms of the vaginal tract, in children who are treated with antibiotics or inhaled glucocorticoids, and in immunocompromised children. (See <a href=\"topic.htm?path=treatment-of-oropharyngeal-and-esophageal-candidiasis\" class=\"medical medical_review\">&quot;Treatment of oropharyngeal and esophageal candidiasis&quot;</a> and <a href=\"topic.htm?path=candida-infections-in-children#H3\" class=\"medical medical_review\">&quot;Candida infections in children&quot;, section on 'Oropharyngeal candidiasis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Aphthous ulcers &ndash; Aphthae, also called canker sores, are painful oral lesions that appear as localized, shallow, round to oval ulcers with a grayish base (<a href=\"image.htm?imageKey=PEDS%2F56488%7EDERM%2F63475\" class=\"graphic graphic_picture graphicRef56488 graphicRef63475 \">picture 11A-B</a>). They are not preceded by vesicles and occur exclusively on nonkeratinized mucosal surfaces; lesions on the lips and perioral lesions exclude a diagnosis of aphthous ulcer. (See <a href=\"topic.htm?path=oral-lesions#H16\" class=\"medical medical_review\">&quot;Oral lesions&quot;, section on 'Aphthous ulcerations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stevens-Johnson syndrome &ndash; Stevens-Johnson syndrome is characterized by a prodrome of malaise and fever, followed by the rapid onset of erythematous or purpuric macules and plaques. The skin lesions progress to epidermal necrosis and sloughing. Mucosal membranes are affected in at least 90 percent of patients. (See <a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beh&ccedil;et syndrome &ndash; Beh&ccedil;et syndrome is characterized by recurrent oral aphthae and any of several systemic manifestations, including genital aphthae, ocular disease, skin lesions, gastrointestinal involvement, neurologic disease, vascular disease, or arthritis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-behcet-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Beh&ccedil;et syndrome&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">MANAGEMENT</span></p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Natural history</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The natural history of herpes simplex virus type 1 (HSV-1) gingivostomatitis was evaluated in a prospective study of 36 children who presented with clinical manifestations lasting &lt;72 hours and were followed with examination and viral culture every two to three days until symptoms resolved [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/12\" class=\"abstract_t\">12</a>]. The mean duration of signs and symptoms was as follows:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fever &ndash; 4.4 days (range 0 to 8 days)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral lesions &ndash; 12 days (range 7 to 18)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Extraoral lesions &ndash; 12 days (range 0 to 19)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eating difficulty &ndash; 9.1 days (range 4 to 17)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drinking difficulty &ndash; 7.1 days (no range provided)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drooling &ndash; 6.6 days (range 0 to 13)</p><p/><p>Viral shedding persisted for a mean of 7.1 days (range 2 to 12 days) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/12\" class=\"abstract_t\">12</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Indications for hospitalization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Indications for hospitalization in children with herpetic gingivostomatitis may include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inability to maintain adequate hydration (see <a href=\"topic.htm?path=clinical-assessment-and-diagnosis-of-hypovolemia-dehydration-in-children\" class=\"medical medical_review\">&quot;Clinical assessment and diagnosis of hypovolemia (dehydration) in children&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immunocompromised host (such children should be treated with intravenous or oral <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a>) (see <a href=\"#H21\" class=\"local\">'Immunocompromised children'</a> below)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eczema herpeticum</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Encephalitis, epiglottitis, or pneumonitis (such children should be treated with intravenous <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a>) (see <a href=\"topic.htm?path=acute-viral-encephalitis-in-children-clinical-manifestations-and-diagnosis#H2\" class=\"medical medical_review\">&quot;Acute viral encephalitis in children: Clinical manifestations and diagnosis&quot;, section on 'Clinical features'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection#H23\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of herpes simplex virus type 1 infection&quot;, section on 'Respiratory tract infections'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpetic keratitis &ndash; Although herpetic keratitis usually can be treated with topical <span class=\"nowrap\">and/or</span> oral medications, admission may be necessary if there are concerns about adherence to the treatment regimen</p><p/><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Supportive care</span></p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Fluid intake</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Maintenance of hydration is a major component of the management of herpetic gingivostomatitis. Fluid intake should be encouraged to avoid dehydration. Analgesics, antipyretics, and oral rinses may make the child more comfortable and help to increase fluid intake. Children who are unable to drink sufficiently to maintain hydration should be hospitalized for parenteral fluid therapy [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The assessment of hydration status and treatment of dehydration are discussed separately. (See <a href=\"topic.htm?path=clinical-assessment-and-diagnosis-of-hypovolemia-dehydration-in-children\" class=\"medical medical_review\">&quot;Clinical assessment and diagnosis of hypovolemia (dehydration) in children&quot;</a> and <a href=\"topic.htm?path=maintenance-fluid-therapy-in-children\" class=\"medical medical_review\">&quot;Maintenance fluid therapy in children&quot;</a> and <a href=\"topic.htm?path=treatment-of-hypovolemia-dehydration-in-children\" class=\"medical medical_review\">&quot;Treatment of hypovolemia (dehydration) in children&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Pain control</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adequate pain control may facilitate fluid intake. Oral <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">acetaminophen</a> or <a href=\"topic.htm?path=ibuprofen-pediatric-drug-information\" class=\"drug drug_pediatric\">ibuprofen</a> may be administered if the child can take them. In severe cases, such as inability to sleep, oral opiates may be required. Opiates should be used with caution; potential adverse effects include respiratory depression, central nervous system depression, hypotension, and constipation.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Topical therapies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest application of a barrier cream (eg, petroleum jelly) to the lips to prevent adhesions in young children with HSV gingivostomatitis [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/19\" class=\"abstract_t\">19</a>]. We do not routinely suggest other topical therapies (eg, &quot;magic mouthwash&quot;) to coat lesions <span class=\"nowrap\">and/or</span> soothe pain given the lack of evidence of benefit from clinical trials, the potential for harm (eg, toxicity from systemic absorption, allergic reaction), and difficulty of application in young children [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/3\" class=\"abstract_t\">3</a>].</p><p>&quot;Magic mouthwash&quot; consists of various combinations of <a href=\"topic.htm?path=diphenhydramine-pediatric-drug-information\" class=\"drug drug_pediatric\">diphenhydramine</a>, magnesia-alumina (eg, Maalox), Kaolin pectin (eg, Kaopectate), <span class=\"nowrap\">and/or</span> viscous <a href=\"topic.htm?path=lidocaine-pediatric-drug-information\" class=\"drug drug_pediatric\">lidocaine</a>. There is no standardized &quot;recipe,&quot; volume, frequency of administration, or mode of application (eg, swish and spit, swish and swallow, apply with swab) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/3\" class=\"abstract_t\">3</a>]. The inclusion of viscous lidocaine is controversial. In a randomized trial, oral fluid intake was similar among children presenting to the emergency department with acute infectious oral ulcers and decreased oral intake one hour after receiving viscous lidocaine or placebo (8.5 versus 9.3 <span class=\"nowrap\">mL/kg,</span> respectively) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/21\" class=\"abstract_t\">21</a>].</p><p>Zilactin, a nonprescription topical medication containing <a href=\"topic.htm?path=lidocaine-pediatric-drug-information\" class=\"drug drug_pediatric\">lidocaine</a> and <a href=\"topic.htm?path=hydroxypropyl-cellulose-drug-information\" class=\"drug drug_general\">hydroxypropyl cellulose</a>, which adheres to mucosa, may be used to protect lesions from trauma and irritants [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/22\" class=\"abstract_t\">22</a>]. ORA5, another nonprescription topical therapy (0.11% <span class=\"nowrap\">iodine/potassium-iodide/copper</span> sulfate solution) works by the same mechanism. Published studies regarding the efficacy and safety of Zilactin and ORA5 in young children with herpetic gingivostomatitis are lacking.</p><p>Topical therapies are potentially problematic for a number of reasons:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Systemic absorption of <a href=\"topic.htm?path=diphenhydramine-pediatric-drug-information\" class=\"drug drug_pediatric\">diphenhydramine</a>, <a href=\"topic.htm?path=lidocaine-pediatric-drug-information\" class=\"drug drug_pediatric\">lidocaine</a>, or <a href=\"topic.htm?path=benzocaine-pediatric-drug-information\" class=\"drug drug_pediatric\">benzocaine</a> may result in toxicity or adverse effects, such as sedation or seizures [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/3,23\" class=\"abstract_t\">3,23</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Topical <a href=\"topic.htm?path=benzocaine-pediatric-drug-information\" class=\"drug drug_pediatric\">benzocaine</a> may cause methemoglobinemia and should not be used in children younger than two years [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/24\" class=\"abstract_t\">24</a>]. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-methemoglobinemia#H6\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of methemoglobinemia&quot;, section on 'Acquired causes'</a> and <a href=\"topic.htm?path=topical-anesthetics-in-children\" class=\"medical medical_review\">&quot;Topical anesthetics in children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Viscous <a href=\"topic.htm?path=lidocaine-pediatric-drug-information\" class=\"drug drug_pediatric\">lidocaine</a> may predispose to self-injury if the child chews on anesthetized oral mucosa or chokes on secretions secondary to pharyngeal anesthesia [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/15,23\" class=\"abstract_t\">15,23</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most children in the gingivostomatitis age group are unable to swish and spit [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/3,25\" class=\"abstract_t\">3,25</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Young children with painful oral lesions are unlikely to allow manipulation of inflamed mucosa for application with a swab [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/3\" class=\"abstract_t\">3</a>].</p><p/><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Oral acyclovir</span></p><p class=\"headingAnchor\" id=\"H30286066\"><span class=\"h3\">Indications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest oral <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> for immune-competent children with herpetic gingivostomatitis who present within 72 to 96 hours of disease onset if they are unable to drink or have significant pain [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/26-30\" class=\"abstract_t\">26-30</a>]. Oral acyclovir also may be beneficial for children with less significant disease, particularly if they attend child care. Topical acyclovir has no effect. Treatment of immunocompromised children is discussed below. (See <a href=\"#H21\" class=\"local\">'Immunocompromised children'</a> below.)</p><p>A systematic review [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/27\" class=\"abstract_t\">27</a>], randomized trials [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/26,28\" class=\"abstract_t\">26,28</a>], and observational studies [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/29,30\" class=\"abstract_t\">29,30</a>] indicate that initiation of oral <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> during the first three to four days of clinical manifestations is beneficial in decreasing the duration of symptoms. It also may shorten the period of viral shedding [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/26\" class=\"abstract_t\">26</a>]. In the largest randomized placebo-controlled trial, treatment with oral acyclovir 15 <span class=\"nowrap\">mg/kg</span> five times per day (maximum single dose 200 mg) for five to seven days within 72 hours of the onset of lesions was associated with [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/26\" class=\"abstract_t\">26</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Shorter duration of lesions (median 4 versus 10 days)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Earlier disappearance of fever (1 versus 3 days)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Earlier resolution of extraoral lesions (0 versus 5.5 days)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased duration of eating difficulties (4 versus 7 days)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reduced viral shedding (1 versus 5 days)</p><p/><p class=\"headingAnchor\" id=\"H30286073\"><span class=\"h3\">Dose and duration</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no consensus regarding the optimal dose or duration of treatment [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/27\" class=\"abstract_t\">27</a>]. We use <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> 15 <span class=\"nowrap\">mg/kg</span> by mouth (maximum single dose 200 mg) five times per day for five to seven days.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Adverse effects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adverse effects of <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> include nausea, vomiting, diarrhea, headaches, and renal failure caused by crystallization in the renal tubules, which is more likely if the patient is dehydrated [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/27\" class=\"abstract_t\">27</a>]. Theoretic concerns about the possible selection of acyclovir-resistant strains of HSV-1 and earlier and more severe recurrences in treated patients have not been demonstrated in patients treated with short courses of acyclovir [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/27,31\" class=\"abstract_t\">27,31</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Topical antivirals</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Topical antiviral agents (<a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a>, <a href=\"topic.htm?path=penciclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">penciclovir</a>, <a href=\"topic.htm?path=docosanol-drug-information\" class=\"drug drug_general\">docosanol</a>) are not helpful in the treatment of primary herpes gingivostomatitis in immunocompetent patients and are not recommended [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4,32\" class=\"abstract_t\">4,32</a>]. However, topical acyclovir (5% ointment every six hours for seven days) may speed the resolution of lesions in immunocompromised children.</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Immunocompromised children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Randomized controlled trials in immunocompromised patients with mucocutaneous HSV infection have demonstrated that <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> (intravenous or oral) is associated with shorter duration of development of new lesions, earlier crusting of lesions, and shorter duration of pain and viral shedding [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/33-36\" class=\"abstract_t\">33-36</a>].</p><p>Dosing for systemic <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> is as follows [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/37\" class=\"abstract_t\">37</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intravenous (IV) &ndash; 30 <span class=\"nowrap\">mg/kg</span> per day IV divided in three doses (for children of all ages)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral &ndash; 1000 <span class=\"nowrap\">mg/day</span> divided in three to five doses (for children &ge;2 years)</p><p/><p>The total duration of treatment is 7 to 14 days.</p><p>In the event that IV <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> is not available (eg, during a shortage, when existing supplies are reserved for neonates with HSV, individuals with HSV encephalitis, and pregnant women), alternatives to IV acyclovir are discussed separately. (See <a href=\"topic.htm?path=acyclovir-an-overview#H620875503\" class=\"medical medical_review\">&quot;Acyclovir: An overview&quot;, section on 'If there is an acyclovir shortage'</a>.)</p><p>Acyclovir-resistant HSV should be suspected in children with a prolonged course of HSV stomatitis despite parenteral <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4\" class=\"abstract_t\">4</a>]. <a href=\"topic.htm?path=foscarnet-pediatric-drug-information\" class=\"drug drug_pediatric\">Foscarnet</a> 80 to 120 <span class=\"nowrap\">mg/kg</span> per day in two to three divided doses has been recommended as the drug of choice for acyclovir-resistant HSV [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Antibiotic therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antibiotics are not routinely administered unless a secondary bacterial infection is diagnosed. If a secondary bacterial infection develops, then antibiotics (eg, <a href=\"topic.htm?path=amoxicillin-pediatric-drug-information\" class=\"drug drug_pediatric\">amoxicillin</a> or <a href=\"topic.htm?path=clindamycin-pediatric-drug-information\" class=\"drug drug_pediatric\">clindamycin</a> in patients with penicillin allergy) may be administered for 7 to 10 days. Secondary infections are uncommon but should be considered if there is a worsening of the child's symptoms (eg, new onset fever) after a period of gradual recovery.</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">PREVENTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oral herpes simplex virus (HSV) infections are common in young children. Most of these infections are asymptomatic, with shedding of virus in the absence of clinical disease.</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Child care</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with gingivostomatitis who do not have control of oral secretions should be excluded from child <span class=\"nowrap\">care/school</span> [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h2\">Isolation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Contact precautions are recommended for hospitalized children with severe mucocutaneous HSV disease (in addition to standard precautions) [<a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/4\" class=\"abstract_t\">4</a>]. (See <a href=\"topic.htm?path=infection-prevention-precautions-for-preventing-transmission-of-infection#H954996324\" class=\"medical medical_review\">&quot;Infection prevention: Precautions for preventing transmission of infection&quot;, section on 'Contact precautions'</a>.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpetic gingivostomatitis is caused by herpes simplex virus type 1 (HSV-1). (See <a href=\"#H3\" class=\"local\">'Virology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HSV-1 gingivostomatitis typically occurs in children between six months and five years of age. It occurs throughout the year. (See <a href=\"#H4\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Herpetic gingivostomatitis is characterized by ulcerative lesions of the gingiva and mucous membranes of the mouth (<a href=\"image.htm?imageKey=PEDS%2F58944\" class=\"graphic graphic_picture graphicRef58944 \">picture 1</a>), often with perioral vesicular lesions (<a href=\"image.htm?imageKey=PEDS%2F58542\" class=\"graphic graphic_picture graphicRef58542 \">picture 2</a>). The oral and extraoral lesions follow a prodrome of fever and constitutional symptoms. The lesions begin as vesicles, which coalesce to form painful ulcers with generalized edematous and bleeding gingiva (<a href=\"image.htm?imageKey=PEDS%2F58944\" class=\"graphic graphic_picture graphicRef58944 \">picture 1</a>). Associated findings include fever, bad breath, refusal to drink, anorexia, and submandibular or cervical lymphadenitis. (See <a href=\"#H8\" class=\"local\">'Complications'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dehydration is the most common complication. Less common complications include spread of HSV to other sites (eg, herpetic whitlow (<a href=\"image.htm?imageKey=DERM%2F75510\" class=\"graphic graphic_picture graphicRef75510 \">picture 5A</a>), herpetic keratitis (<a href=\"image.htm?imageKey=ID%2F69359\" class=\"graphic graphic_picture graphicRef69359 \">picture 6</a>), encephalitis, esophagitis, pneumonitis, eczema herpeticum (<a href=\"image.htm?imageKey=PC%2F74838\" class=\"graphic graphic_picture graphicRef74838 \">picture 7</a>)), secondary bacteremia, and lip adhesions. (See <a href=\"#H8\" class=\"local\">'Complications'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of gingivostomatitis usually is made clinically based upon the typical appearance and location of oral and extraoral lesions (<a href=\"image.htm?imageKey=PEDS%2F58542\" class=\"graphic graphic_picture graphicRef58542 \">picture 2</a> and <a href=\"image.htm?imageKey=PEDS%2F58944\" class=\"graphic graphic_picture graphicRef58944 \">picture 1</a>). If necessary, HSV-1 can be confirmed with viral culture, serology, immunofluorescence, or polymerase chain reaction. (See <a href=\"#H9\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The differential diagnosis of HSV-1 gingivostomatitis includes herpangina; hand, foot, and mouth disease (<a href=\"image.htm?imageKey=PEDS%2F52800%7EDERM%2F58566%7EDERM%2F53423%7EDERM%2F71314\" class=\"graphic graphic_picture graphicRef52800 graphicRef58566 graphicRef53423 graphicRef71314 \">picture 9A-D</a>); oral candidiasis (<a href=\"image.htm?imageKey=PEDS%2F69465\" class=\"graphic graphic_picture graphicRef69465 \">picture 10</a>); aphthous ulcers (<a href=\"image.htm?imageKey=PEDS%2F56488%7EDERM%2F63475\" class=\"graphic graphic_picture graphicRef56488 graphicRef63475 \">picture 11A-B</a>); Stevens-Johnson syndrome; and Beh&ccedil;et syndrome. The presence, appearance, and location of oral and extraoral lesions help to distinguish HSV-1 gingivostomatitis from these conditions. (See <a href=\"#H10\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Supportive care, with an emphasis on maintenance of hydration, is the mainstay of therapy. (See <a href=\"#H15\" class=\"local\">'Fluid intake'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest application of a barrier cream (eg, petroleum jelly) to the lips to prevent adhesions in young children with HSV gingivostomatitis (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). We do not suggest topical therapies containing <a href=\"topic.htm?path=lidocaine-pediatric-drug-information\" class=\"drug drug_pediatric\">lidocaine</a> (<a href=\"grade.htm?i=5\" class=\"grade\">Grade 2B</a>) or other topical therapies (eg, <a href=\"topic.htm?path=diphenhydramine-pediatric-drug-information\" class=\"drug drug_pediatric\">diphenhydramine</a>, Kaolin pectin) (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>) to coat the lesions or soothe pain in children with HSV gingivostomatitis. (See <a href=\"#H17\" class=\"local\">'Topical therapies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest oral <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> for immune-competent children with herpetic gingivostomatitis who present within 72 to 96 hours of disease onset if they are unable to drink or have significant pain (<a href=\"grade.htm?i=4\" class=\"grade\">Grade 2A</a>). We use 15 <span class=\"nowrap\">mg/kg</span> (maximum single dose 200 mg) five times per day for five to seven days. (See <a href=\"#H18\" class=\"local\">'Oral acyclovir'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We use systemic <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">acyclovir</a> (intravenous [IV] or oral) for immunocompromised children with herpetic gingivostomatitis (see <a href=\"#H21\" class=\"local\">'Immunocompromised children'</a> above):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For children of all ages &ndash; <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">Acyclovir</a> 30 <span class=\"nowrap\">mg/kg</span> per day IV divided in three doses for 7 to 14 days</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>For children &ge;2 years &ndash; <a href=\"topic.htm?path=acyclovir-pediatric-drug-information\" class=\"drug drug_pediatric\">Acyclovir</a> 1000 <span class=\"nowrap\">mg/day</span> orally divided in three to five doses for 7 to 14 days</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/1\" class=\"nounderline abstract_t\">Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect 2006; 12:202.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/2\" class=\"nounderline abstract_t\">Kimberlin DW. Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis 2005; 16:271.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/3\" class=\"nounderline abstract_t\">Faden H. Management of primary herpetic gingivostomatitis in young children. Pediatr Emerg Care 2006; 22:268.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Herpes simplex. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.432.</li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/5\" class=\"nounderline abstract_t\">Richardson M, Elliman D, Maguire H, et al. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 2001; 20:380.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/6\" class=\"nounderline abstract_t\">Daniels CA, LeGoff SG. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Lancet 1975; 2:524.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/7\" class=\"nounderline abstract_t\">Manzella JP, McConville JH, Valenti W, et al. An outbreak of herpes simplex virus type I gingivostomatitis in a dental hygiene practice. JAMA 1984; 252:2019.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/8\" class=\"nounderline abstract_t\">Amir J. Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis. Paediatr Drugs 2001; 3:593.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/9\" class=\"nounderline abstract_t\">Cesario TC, Poland JD, Wulff H, et al. Six years experience with herpes simplex virus in a children's home. Am J Epidemiol 1969; 90:416.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/10\" class=\"nounderline abstract_t\">Schmitt DL, Johnson DW, Henderson FW. Herpes simplex type 1 infections in group day care. Pediatr Infect Dis J 1991; 10:729.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/11\" class=\"nounderline abstract_t\">Becker TM, Magder L, Harrison HR, et al. The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidemiol 1988; 127:1071.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/12\" class=\"nounderline abstract_t\">Amir J, Harel L, Smetana Z, Varsano I. The natural history of primary herpes simplex type 1 gingivostomatitis in children. Pediatr Dermatol 1999; 16:259.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/13\" class=\"nounderline abstract_t\">Kuzushima K, Kimura H, Kino Y, et al. Clinical manifestations of primary herpes simplex virus type 1 infection in a closed community. Pediatrics 1991; 87:152.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/14\" class=\"nounderline abstract_t\">King DL, Steinhauer W, Garc&iacute;a-Godoy F, Elkins CJ. Herpetic gingivostomatitis and teething difficulty in infants. Pediatr Dent 1992; 14:82.</a></li><li class=\"breakAll\">Harrison GJ, Pinsky BA, Arvin AM. Herpes simplex viruses 1 and 2. In: Feigin and Cherry&rsquo;s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2018. p.1403.</li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/16\" class=\"nounderline abstract_t\">Amir J, Yagupsky P. Invasive Kingella kingae infection associated with stomatitis in children. Pediatr Infect Dis J 1998; 17:757.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/17\" class=\"nounderline abstract_t\">Amir J, Nussinovitch M, Straussberg R, Harel L. Bacteremia with group A Streptococcus associated with herpetic gingivostomatitis. Pediatr Infect Dis J 2001; 20:916.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/18\" class=\"nounderline abstract_t\">Bogger-Goren S. Acute epiglottitis caused by herpes simplex virus. Pediatr Infect Dis J 1987; 6:1133.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/19\" class=\"nounderline abstract_t\">Thomas E. A complication of primary herpetic gingivostomatitis. Br Dent J 2007; 203:33.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/20\" class=\"nounderline abstract_t\">PARROTT RH, WOLF SI, NUDELMAN J, et al. Clinical and laboratory differentiation between herpangina and infectious (herpetic) gingivostomatitis. Pediatrics 1954; 14:122.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/21\" class=\"nounderline abstract_t\">Hopper SM, McCarthy M, Tancharoen C, et al. Topical lidocaine to improve oral intake in children with painful infectious mouth ulcers: a blinded, randomized, placebo-controlled trial. Ann Emerg Med 2014; 63:292.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/22\" class=\"nounderline abstract_t\">Rodu B, Mattingly G. Oral mucosal ulcers: diagnosis and management. J Am Dent Assoc 1992; 123:83.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/23\" class=\"nounderline abstract_t\">Hess GP, Walson PD. Seizures secondary to oral viscous lidocaine. Ann Emerg Med 1988; 17:725.</a></li><li class=\"breakAll\">Questions &amp; Answers: Reports of a rare, but serious and potentially fatal adverse effect with the use of over-the-counter (OTC) benzocaine gels and liquids applied to the gums or mouth www.fda.gov/Drugs/DrugSafety/ucm250029.htm (Accessed on August 03, 2012).</li><li class=\"breakAll\">McDonald RE, Avery DR, Stookey GK. Dental caries in the child and adolescent. In: Dentistry for the Child and Adolescent, 7th ed, McDonald RE, Avery DR (Eds), Mosby, Philadelphia 2000. p.209.</li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/26\" class=\"nounderline abstract_t\">Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ 1997; 314:1800.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/27\" class=\"nounderline abstract_t\">Hudson B, Powell C. Towards evidence based medicine for paediatricians. Does oral aciclovir improve clinical outcome in immunocompetent children with primary herpes simplex gingivostomatitis? Arch Dis Child 2009; 94:165.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/28\" class=\"nounderline abstract_t\">Ducoulombier H, Cousin J, Dewilde A, et al. [Herpetic stomatitis-gingivitis in children: controlled trial of acyclovir versus placebo]. Ann Pediatr (Paris) 1988; 35:212.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/29\" class=\"nounderline abstract_t\">Cataldo F, Violante M, Maltese I, et al. [Herpetic gingivostomatitis in children: the clinico-epidemiological aspects and findings with acyclovir treatment. A report of the cases of 162 patients]. Pediatr Med Chir 1993; 15:193.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/30\" class=\"nounderline abstract_t\">Mueller R, Weigand KH. The treatment of herpetic gingivostomatitis with aciclovir suspension. Der Kinderarzt 1988; 19:1189.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/31\" class=\"nounderline abstract_t\">Murph JR, Grose C. Routine acyclovir therapy: isn't it time? Contemp Pediatr 1999; 16:79.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/32\" class=\"nounderline abstract_t\">Whitley RJ, Gnann JW Jr. Acyclovir: a decade later. N Engl J Med 1992; 327:782.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/33\" class=\"nounderline abstract_t\">Meyers JD, Wade JC, Mitchell CD, et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 1982; 73:229.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/34\" class=\"nounderline abstract_t\">Mitchell CD, Bean B, Gentry SR, et al. Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet 1981; 1:1389.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/35\" class=\"nounderline abstract_t\">Wade JC, Newton B, McLaren C, et al. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med 1982; 96:265.</a></li><li><a href=\"https://www.uptodate.com/contents/herpetic-gingivostomatitis-in-young-children/abstract/36\" class=\"nounderline abstract_t\">Shepp DH, Newton BA, Dandliker PS, et al. Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients. Ann Intern Med 1985; 102:783.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Non-HIV antiviral drugs. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, 2015. p.919.</li></ol></div><div id=\"topicVersionRevision\">Topic 6046 Version 28.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H26\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PATHOGENESIS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">VIROLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">EPIDEMIOLOGY</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Transmission</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Incubation period</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">CLINICAL FEATURES</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">COMPLICATIONS</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">DIAGNOSIS</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">MANAGEMENT</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">Natural history</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Indications for hospitalization</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Supportive care</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">- Fluid intake</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">- Pain control</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- Topical therapies</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">Oral acyclovir</a><ul><li><a href=\"#H30286066\" id=\"outline-link-H30286066\">- Indications</a></li><li><a href=\"#H30286073\" id=\"outline-link-H30286073\">- Dose and duration</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">- Adverse effects</a></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">Topical antivirals</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Immunocompromised children</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Antibiotic therapy</a></li></ul></li><li><a href=\"#H23\" id=\"outline-link-H23\">PREVENTION</a><ul><li><a href=\"#H24\" id=\"outline-link-H24\">Child care</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">Isolation</a></li></ul></li><li><a href=\"#H26\" id=\"outline-link-H26\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/6046|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/58944\" class=\"graphic graphic_picture\">- HSV gingivostomatitis</a></li><li><a href=\"image.htm?imageKey=PEDS/58542\" class=\"graphic graphic_picture\">- Herpetic stomatitis</a></li><li><a href=\"image.htm?imageKey=PEDS/73566\" class=\"graphic graphic_picture\">- HSV lip</a></li><li><a href=\"image.htm?imageKey=PEDS/115299\" class=\"graphic graphic_picture\">- Cold sore</a></li><li><a href=\"image.htm?imageKey=DERM/75510\" class=\"graphic graphic_picture\">- Herpetic whitlow</a></li><li><a href=\"image.htm?imageKey=ID/52029\" class=\"graphic graphic_picture\">- Herpetic whitlow finger</a></li><li><a href=\"image.htm?imageKey=ID/69359\" class=\"graphic graphic_picture\">- Herpes simplex keratitis</a></li><li><a href=\"image.htm?imageKey=PC/74838\" class=\"graphic graphic_picture\">- Eczema herpeticum hand</a></li><li><a href=\"image.htm?imageKey=PC/64142\" class=\"graphic graphic_picture\">- Eczema herpeticum face</a></li><li><a href=\"image.htm?imageKey=PEDS/52800\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - lip and hand</a></li><li><a href=\"image.htm?imageKey=DERM/58566\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - buccal</a></li><li><a href=\"image.htm?imageKey=DERM/53423\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - foot</a></li><li><a href=\"image.htm?imageKey=DERM/71314\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - tongue</a></li><li><a href=\"image.htm?imageKey=PEDS/69465\" class=\"graphic graphic_picture\">- Three examples of thrush (oral candidiasis) in an infant</a></li><li><a href=\"image.htm?imageKey=PEDS/56488\" class=\"graphic graphic_picture\">- Aphthous ulcer</a></li><li><a href=\"image.htm?imageKey=DERM/63475\" class=\"graphic graphic_picture\">- Aphthous ulcers</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-viral-encephalitis-in-children-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute viral encephalitis in children: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acyclovir-an-overview\" class=\"medical medical_review\">Acyclovir: An overview</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candida-infections-in-children\" class=\"medical medical_review\">Candida infections in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-assessment-and-diagnosis-of-hypovolemia-dehydration-in-children\" class=\"medical medical_review\">Clinical assessment and diagnosis of hypovolemia (dehydration) in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-methemoglobinemia\" class=\"medical medical_review\">Clinical features, diagnosis, and treatment of methemoglobinemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-behcet-syndrome\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Beh&ccedil;et syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of herpes simplex virus type 1 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-clinical-features-laboratory-diagnosis-treatment-and-prevention\" class=\"medical medical_review\">Enterovirus and parechovirus infections: Clinical features, laboratory diagnosis, treatment, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=enterovirus-and-parechovirus-infections-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Enterovirus and parechovirus infections: Epidemiology and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">Epidemiology of herpes simplex virus type 1 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=herpes-simplex-keratitis\" class=\"medical medical_review\">Herpes simplex keratitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=herpes-simplex-virus-type-1-encephalitis\" class=\"medical medical_review\">Herpes simplex virus type 1 encephalitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infection-prevention-precautions-for-preventing-transmission-of-infection\" class=\"medical medical_review\">Infection prevention: Precautions for preventing transmission of infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=maintenance-fluid-therapy-in-children\" class=\"medical medical_review\">Maintenance fluid therapy in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Management and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures\" class=\"medical medical_review\">Office-based dermatologic diagnostic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=oral-lesions\" class=\"medical medical_review\">Oral lesions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=paronychia\" class=\"medical medical_review\">Paronychia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-herpes-simplex-virus-type-1-infection\" class=\"medical medical_review\">Pathogenesis of herpes simplex virus type 1 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=topical-anesthetics-in-children\" class=\"medical medical_review\">Topical anesthetics in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-herpes-simplex-virus-type-1-infection-in-immunocompetent-patients\" class=\"medical medical_review\">Treatment of herpes simplex virus type 1 infection in immunocompetent patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-hypovolemia-dehydration-in-children\" class=\"medical medical_review\">Treatment of hypovolemia (dehydration) in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-oropharyngeal-and-esophageal-candidiasis\" class=\"medical medical_review\">Treatment of oropharyngeal and esophageal candidiasis</a></li></ul></div></div>","javascript":null}